Aller au contenu principal
Profil bibliographique

Chen‐Pin Wang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

26Publications signalées
179Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsHIV Research and TreatmentHealth disparities and outcomes

Les publications récentes

Accès ouvert 2026 article OpenAlex

Frontotemporal dementia in Hispanic populations: Regional and national comparisons

Shannon B. Lavigne, Gabrielle Hromas, Ashley LaRoche, Alicia S. Parker et autres

Abstract INTRODUCTION Although Hispanic/Latine populations experience higher dementia rates, they remain underrepresented in frontotemporal dementia (FTD) research. This study examines clinical manifestations of FTD within a South Texas Hispanic/Latine cohort compared to national data. METHODS Participants diagnosed with FTD were included from …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Accès ouvert 2025 article OpenAlex

Cardiovascular Risk Factors and Cognitive Function ‐ Generalizing Results from a Clinical Cohort

Janette Vazquez, Ashley LaRoche, Daniel MacCarthy, Roman Fernandez et autres

BACKGROUND: Generalizing dementia research findings from clinical studies to broader populations is challenging due to selective participation. This study evaluated associations between cardiovascular risk factors and cognitive function in the South Texas Alzheimer's Disease Research Center cohort (STAC), leveraging 2023 Behavioral Risk …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Chronic HIV Infection Association with Cognition and ADRD Plasma Biomarkers in Uganda

Jeremy A. Tanner, Roslyn Valdespino, Tiffany F. Kautz, Godfrey Masette et autres

Abstract Background Sub‐Saharan Africa (sSA) is projected to have the fastest population growth in older adults globally, a >250% increase in Alzheimer's Disease (AD), and rapid growth in older people living with HIV (PLWH) well‐treated on antiretroviral therapies (ARTs) in the coming …

us, Ouganda, gb (code pays fourni par la source)

1 citation Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Adaptation and Validation of Brief Tablet‐Based Cognitive Assessment Tool in Uganda

Roslyn Valdespino, Gabrielle Hromas, Chen‐Pin Wang, Robert Paul et autres

BACKGROUND: Sub-Saharan Africa (SSA) faces accelerated growth of older adults, older people living with HIV (PLWH), and Alzheimer's Disease (AD). However, there is a shortage of human resources and contextually relevant diagnostic tools to assess cognitive impairment (CI) in the region. The …

us, Ouganda, gb (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Pharmacological targeting of tau‐induced retrotransposon activation

A. Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, Roman Fernandez et autres

BACKGROUND: Approximately 40% of the human genome is composed of retrotransposons, virus-like sequences that are typically silenced at the transcriptional and post-transcriptional levels. We have previously discovered that retrotransposons are activated in a variety of human neurodegenerative disorders, including Alzheimer's disease and …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Feasibility of a pragmatic clinical trial model in Lewy body disease and its effects on recruitment, retention, and diversity of study participants

Sarah Horn, Chen‐Pin Wang, Pablo Coss, Okeanis Vaou et autres

BACKGROUND: Both quetiapine and pimavanserin are commonly used in clinical practice for psychosis (hallucinations and/or delusions) in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) - collectively referred to as Lewy body disease (LBD). Clinical trials to establish efficacy have been …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Determining Language of Neuropsychological Assessment in a Bilingual Population

Gabrielle Hromas, Stephanie Santiago-Mejías, Chen‐Pin Wang, Roman Fernandez et autres

BACKGROUND: Determining the language of neuropsychological assessment in a bilingual patient population is difficult with implications for test performance and clinical interpretation. We compared two methods of identifying language dominance for neuropsychological testing in a sample of bilingual (English/Spanish) Hispanic/Latine patients in …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Plasma Biomarker Association with Cognition in Uganda

Jeremy A. Tanner, Roslyn Valdespino, Tiffany F. Kautz, Godfrey Masette et autres

Abstract Background Over 60% of individuals with ADRDs live in low‐ and middle‐income countries (LMICs). Sub‐Saharan Africa (SSA) is projected to have the fastest growth in older adults, including people living with HIV (PLWH). Plasma ADRD biomarkers are promising diagnostic tools, but …

us, Ouganda, gb (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2024 article OpenAlex

Multi Site Comparison of Participant Profiles in the South Texas Alzheimer’s Disease Research Center

Jennifer G Del Bosque, Chen‐Pin Wang, Roman Fernandez, Jeremy A. Tanner et autres

BACKGROUND: Hispanic adults comprise 19% of the US population, yet <8% of Alzheimer's Disease and Related Dementia (ADRD) research cohorts. Hispanic adults in the US are 1.5 times more likely to develop ADRDs compared to Non-Hispanics. Considering the projected growth in Hispanics …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2024 article OpenAlex

Instrumental and biological validation of PSMD as a VCID biomarker

Claudia L. Satizábal, Alexa Beiser, Alison M. Luckey, Rebecca Bernal et autres

Abstract Background Peak‐width of skeletonized mean diffusivity (PSMD) is an emerging biomarker of cerebral small vessel disease (cSVD)‐related vascular contributions to cognitive impairment and dementia (VCID). Higher PSMD values reflect greater white matter microstructural damage, and prior research has related PSMD to …

us, se, is (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2024 article OpenAlex

APOE ε4 is associated with risk of clinical Alzheimer’s Disease Dementia independent of Hispanic ethnicity

Amaya M Seidl, Marco I Boisselier, Ashley LaRoche, Chen‐Pin Wang et autres

Abstract Background The Apolipoprotein E (APOE) ε4 variant is the strongest genetic risk factor for Alzheimer’s disease (AD) and has been thoroughly studied in non‐Hispanic whites (NHW). However, its association with AD among Hispanic individuals is unclear, with existing studies yielding mixed …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2024 article OpenAlex

The impact of mid‐life cardiovascular health on cognitive change in a bi‐ethnic cohort

Janette Vazquez, Rebecca Bernal, Hector Trevino, Angel G. Velarde et autres

Abstract Background Vascular risk factors are known contributors to cognitive decline and dementia; however, their impact on cognitive change in diverse samples is understudied. In this study, we investigated the effect of the AHA Life’s Simple 7 (LS7) on cognitive decline in …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.